...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: jkj link re BRD4

Posting link link by jkj on SH. Any thoughts?

http://www.cell.com/cell-reports/fulltext/S2211-1247(17)31915-0

Toinv

Share
New Message
Please login to post a reply